trial · primary record
TQB2102 for injection
HER2-positive Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 544 |
| Primary completion | 2029-09 |
| Primary endpoint | Rate of total physiological complete response (tpCR) evaluated by Independent Review Committee (IRC) |
| Registry ID | NCT07043725 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:44.823Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07043725
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.